Tylenol Articles
Double whammy for Johnson & Johnson, as DoJ sues on alleged “kickbacks,” and Tylenol contamination discovered
18 January 2010
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Opana growth drives Endo's profit up 15%
16 March 2009
FDA panel says Darvon risks outweigh benefits
23 February 2009
FDA warns over use of topical anesthetics
26 January 2009
Acetavance reduces pain after abdomen ops
12 January 2009
USA's Consumer Reports warns pain pills can worsen headaches
8 September 2008
Illegal California pharmacy faces charges
2 June 2008
Cadence loses 46% as Acetavance fails Ph III
21 January 2008
Accentia's FY 2007 loss soars 68% on R&D costs
14 January 2008
PDL's HuLuc63 shows promise in Ph I MM trial
17 December 2007
Headlines 25 years ago this week....
26 November 2007
Auriga signs manufacturing deal with Mikart
12 November 2007
Stores clear pediatric cough and cold remedies from shelves
22 October 2007
Par and Ortho-McNeil resolve Ultracet patent dispute
30 July 2007
Web Rx drugs: "complex and emerging problem"
23 July 2007
Wal-Mart proposes new Rx drug pricing model
4 June 2007
India's OTC drug market boom
23 April 2007
Bogus Canadian web pharmacy's death probe
2 April 2007
Caraco wins generic Ultracet appeal
29 January 2007
Japan to promote pediatric acetaminophen
15 January 2007
J&Js 3rd-qtr profit rises 8.7% to $2.76B
23 October 2006
J&J wins bidding war for Pfizer
3 July 2006
Japan to discuss pediatric drug use
10 April 2006
US FDA approves Accentia's Xodol
3 April 2006
Tentative US approval for Teva's tramadol
25 July 2005
J&J's 17% 1st-qtr earnings rise beats analysts' expectations; firm to buy Peninsula Pharma
25 April 2005
$1B sales milestone for OTC Claritin
4 April 2005
New Zealand views UK co-proxamol withdrawal
14 February 2005
Migrainers snot getting most effective therapy: Datamonitor
7 February 2005
Phased withdrawal of co-proxamol in UK
7 February 2005
Acetaminophen confirmed as first-line OA pain therapy
13 December 2004
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
Sri Lanka clamps down on drug ads
19 July 2004
aaiPharma 1st-qtr net loss rockets
5 July 2004
Par Pharma buys Kali Labs in $135M deal
21 June 2004
Pharmaceutical Resources to buy Kali
19 April 2004
Endo net sales surge 49% in 2003
23 February 2004
Watson revenues in 2003 hit record $1.46B
16 February 2004
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
US FDA to educate about OTC painkillers
2 February 2004
aaiPharma's Darvocet gains FDA approval
22 September 2003
Watson gets FDA OK for generic Percocet
15 September 2003
aaiPharma swings to profit in first quarter
28 April 2003
Novartis completes $178 mill headache drug sale
17 February 2003
B-MS extends injectable acetaminophen deal
3 February 2003
Watson pays $178M for Novartis headache drugs
27 January 2003
J&J
22 July 2002
Alpharma gets generic tramadol go-ahead in USA
1 July 2002
Ranbaxy/Core Pharma deal approved
8 April 2002
Lilly sells pain drugs for $211.4 million
18 March 2002
Ranbaxy gets go-ahead for generic Tylenol version in USA
6 December 2001
NicOx reports results with NO-paracetamol
27 June 2001
Brazil may withdraw dipirone products
21 June 2001
India acts on "dumped" imports from China
24 April 2001
Watson launches four new products
15 January 2001
Stock Commentary Tokyo
27 July 2000
UK acetaminophen curbs "cut overdoses"
13 June 2000
North Asian markets for OTC analgesics
5 August 1999
Third-party payers lead Rx payments
5 May 1999
APhA/McNeil OTC labeling initiative
29 March 1999
Horizon launches tension headache product
11 February 1999
Marinol Reclassified As Schedule III Drug?
18 November 1998
Poor Rxing "Costs UK NHS L100 Mill/Year In England"
28 October 1998
Rx-To-OTC Switches "Not Working Except In USA"
6 October 1998
BASF Acquires Celanese Acetaminophen Business
1 October 1998
New Drugs, Vaccine Shift Balance In War Against Flu
30 September 1998
Perrigo Launch Flashtabs In The USA
19 August 1998
Acetaminophen For Arteriosclerosis?
30 July 1998
Low-Dose Ketoprofen And Gastric Irritation
30 July 1998
J&J Painkillers Get Alcohol Warning
9 July 1998
Takeda Boosts OTC Business With J&J
17 April 1998
OTC Drug Markets In East And Southeast Asia
3 April 1998
Novartis Rapped Over Doan Advertising
20 March 1998
Acetaminophen Halves Ovarian Cancer Risk
19 February 1998
New Data With B-MS' Excedrin Migraine
19 February 1998
First OTC Migraine Drug Is Approved
20 January 1998
Migraine Market Hotting Up In The USA
20 January 1998
FDA Warning On OTC Analgesics
20 November 1997
Knoll's Vicoprofen Approved In USA
16 October 1997
FDA Panels Back Excedrin For Migraine
17 July 1997
US Seniors Surveyed On Pain Relief
3 July 1997
Watson Pharmaceuticals Gains US Approval For Norco
24 February 1997
IDEC Non-Hodgkin's Lymphoma Antibody Clears Phase III Trials
16 December 1996
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
